Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H 2 Receptor Blockers.

Autor: Khawaja M; The Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Thakker J; The Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Kherallah R; The Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Kitakaze M; Center of Medical Innovation and Translational Research, Department of Medical Data Science, Osaka University Graduate School of Medicine, Osaka, Japan., Jneid H; The Section of Cardiology, The Department of Medicine, Baylor College of Medicine, 7200 Cambridge Street, Houston, TX, 77030, USA., Angiolillo DJ; Division of Cardiology, The University of Florida College of Medicine, Jacksonville, FL, USA., Birnbaum Y; The Section of Cardiology, The Department of Medicine, Baylor College of Medicine, 7200 Cambridge Street, Houston, TX, 77030, USA. ybirnbau@bcm.edu.

Publikováno v: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2024 Feb; Vol. 38 (1), pp. 181-189. Date of Electronic Publication: 2022 Jun 18.

Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?

Autor: Albera, Carlo, Antoniou, Katerina M., Altinisik, Goksel, Bendstrup, Elisabeth, Bondue, Benjamin, Borie, Raphael, Brown, Kevin K., Camus, Philippe, Castillo, Diego, Collard, Harold R., Cottin, Vincent, Crimi, Nunzio, Ferrara, Giovanni, Fischer, Aryeh, Gauldie, Jack, Geiser, Thomas, Guenther, Andreas, Hambly, Nathan, Hansell, David M., Harari, Sergio, Jones, Mark G., Keane, Michael, Ley, Brett, Maher, Toby M., Molina-Molina, Maria, Palmucci, Stefano, Poletti, Venerino, Prasse, Antje, Rottoli, Paola, Spagnolo, Paolo, Sterclova, Martina, Torrisi, Sebastiano, Tsitoura, Eliza, Vasakova, Martina, Walsh, Simon L., Wijsenbeek, Marlies S., Wuyts, Wim A., Johannson, Kerri A, Strâmbu, Irina, Ravaglia, Claudia, Grutters, Jan C, Valenzuela, Claudia, Mogulkoc, Nesrin, Luppi, Fabrizio, Richeldi, Luca, Wells, Athol U, Vancheri, Carlo, Kreuter, Michael

Publikováno v: In The Lancet Respiratory Medicine July 2017 5(7):591-598

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry

Autor: Helen E. Jo, Tamera J. Corte, Ian Glaspole, Christopher Grainge, Peter M. A. Hopkins, Yuben Moodley, Paul N. Reynolds, Sally Chapman, E. Haydn Walters, Christopher Zappala, Heather Allan, Gregory J. Keir, Wendy A. Cooper, Annabelle M. Mahar, Samantha Ellis, Sacha Macansh, Nicole S. Goh

Publikováno v: BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-7 (2019)

Abstract Background and objective Gastroesophageal reflux disease (GORD) is highly prevalent in idiopathic pulmonary fibrosis (IPF) and may play a role in its pathogenesis. Recent IPF treatment guidelines suggest that all patients with IPF be conside

Externí odkaz: https://doaj.org/article/e7a23ace75d242ce910465bad83b3312

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Does Antacid Therapy in Idiopathic Pulmonary Fibrosis Patients Increase Risk of Pneumonia? An Observational Cohort Study

Autor: G. Massen, A.D. Morgan, P.M. George, J.K. Quint

Publikováno v: C95. NOT JUST GENES: ENVIRONMENTAL EXPOSURES AND INTERSTITIAL LUNG DISEASE.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::645a0ce0519312f1c21d03309355a3b9
https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a5944